Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,955,315
-$100,669 QoQ
Shares Held
7,699
-8.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#2,372
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $8,063,885 across 15 Drug Manufacturers - General names. JNJ ranks #2 (24.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,004 | $2,265,766 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
7,699 | $1,955,315 | |
| 3 | NVS |
Novartis AG
|
6,281 | $984,358 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,494 | $705,979 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,283 | $541,114 | |
| 6 | LLY |
ELI LILLY & Co
|
450 | $539,743 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,281 | $304,291 | |
| 8 | AMGN |
Amgen Inc
|
657 | $237,912 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,955,315 | 7,699 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,055,984 | 8,411 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $2,067,637 | 9,991 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,867,735 | 10,073 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,548,885 | 10,140 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,705,996 | 10,287 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,473,243 | 10,187 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,667,435 | 10,289 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,649,123 | 11,283 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,804,156 | 11,405 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $1,838,246 | 11,728 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,752,499 | 11,252 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,887,093 | 11,401 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,796,450 | 11,590 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,026,528 | 11,472 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,146,877 | 13,142 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,356,977 | 13,278 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $2,432,481 | 13,725 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,461,184 | 14,387 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $2,236,775 | 13,850 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,281,154 | 13,847 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,243,048 | 13,648 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $2,041,375 | 12,971 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,909,981 | 12,829 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,804,142 | 12,829 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $1,761,731 | 13,435 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||